GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » Cyclically Adjusted PS Ratio

Bruker (Bruker) Cyclically Adjusted PS Ratio : 4.09 (As of Jun. 10, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bruker Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Bruker's current share price is $64.97. Bruker's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $15.87. Bruker's Cyclically Adjusted PS Ratio for today is 4.09.

The historical rank and industry rank for Bruker's Cyclically Adjusted PS Ratio or its related term are showing as below:

BRKR' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.94   Med: 3.3   Max: 7.22
Current: 4.08

During the past years, Bruker's highest Cyclically Adjusted PS Ratio was 7.22. The lowest was 1.94. And the median was 3.30.

BRKR's Cyclically Adjusted PS Ratio is ranked worse than
66.18% of 476 companies
in the Medical Devices & Instruments industry
Industry Median: 2.105 vs BRKR: 4.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bruker's adjusted revenue per share data for the three months ended in Mar. 2024 was $4.947. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $15.87 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bruker Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bruker's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Cyclically Adjusted PS Ratio Chart

Bruker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.46 4.53 6.37 4.76 4.76

Bruker Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.34 4.92 4.07 4.76 5.92

Competitive Comparison of Bruker's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Bruker's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted PS Ratio falls into.



Bruker Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bruker's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=64.97/15.87
=4.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bruker's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.947/131.7762*131.7762
=4.947

Current CPI (Mar. 2024) = 131.7762.

Bruker Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.699 100.560 3.537
201409 2.475 100.428 3.248
201412 2.997 99.070 3.986
201503 2.083 99.621 2.755
201506 2.334 100.684 3.055
201509 2.348 100.392 3.082
201512 2.828 99.792 3.734
201603 2.285 100.470 2.997
201606 2.289 101.688 2.966
201609 2.439 101.861 3.155
201612 2.927 101.863 3.787
201703 2.398 102.862 3.072
201706 2.587 103.349 3.299
201709 2.745 104.136 3.474
201712 3.385 104.011 4.289
201803 2.750 105.290 3.442
201806 2.826 106.317 3.503
201809 2.964 106.507 3.667
201812 3.522 105.998 4.379
201903 2.922 107.251 3.590
201906 3.110 108.070 3.792
201909 3.349 108.329 4.074
201912 3.860 108.420 4.692
202003 2.728 108.902 3.301
202006 2.745 108.767 3.326
202009 3.314 109.815 3.977
202012 4.075 109.897 4.886
202103 3.621 111.754 4.270
202106 3.733 114.631 4.291
202109 3.985 115.734 4.537
202112 4.479 117.630 5.018
202203 3.930 121.301 4.269
202206 3.928 125.017 4.140
202209 4.299 125.227 4.524
202212 4.790 125.222 5.041
202303 4.643 127.348 4.804
202306 4.617 128.729 4.726
202309 5.043 129.860 5.117
202312 5.841 129.419 5.947
202403 4.947 131.776 4.947

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bruker  (NAS:BRKR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bruker Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bruker's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bruker (Bruker) Business Description

Traded in Other Exchanges
Address
40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.
Executives
Frank H Laukien director, 10 percent owner, officer: CEO, President C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821
Marc A Kastner director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Cynthia M Friend director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Richard A Packer director 9 KENDALL DRIVE, WESTBOROUGH MA 01581
Philip Ma director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Mark Munch officer: Pres. Bruker Nano Inc. BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Juergen Srega officer: Group President Bruker CALID BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Burkhard Prause officer: Pres. & CEO, Bruker EST BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Bonnie H Anderson director 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Martin Gilles Gerard Jean director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Falko Busse officer: President, BioSpin Group 40 MANNING ROAD, BILLERICA MA 01821
Gerald N Herman officer: Vice President, Corp Contr. 55 EXECUTIVE DRIVE, HUDSON NH 03051
Ingen Chris Van director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Richard Kniss director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Adelene Q Perkins director C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139